Case Example: ePA Workflow for a GLP-1 Prescription To illustrate, consider a hypothetical case: Patient: 55-year-old female with Type 2 diabetes (HbA1c 8.7%), BMI 34, on metformin + lifestyle modifications
These systems involve dozens of hormones, neural pathways, and feedback loops that resist sustained weight loss
LDL cholesterol, another major heart risk marker, decreases as well, but this can be more personalized
Individuals stop the medication for reasons including high cost, unwanted side effects, or achieving their weight loss goals
Drug interactions Pepto Bismol can interact with NSAIDs, certain antibiotics, corticosteroids, and some heart medications, potentially leading to adverse effects